04202024Sat
Last updateWed, 27 Mar 2024 6am

Mirtazapine and Bupropion Combined Treatment in Treatment-resistant Depression

Chien-Han Lai a, b

aDepartment of Psychiatry, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan
bInstitute of Brain Science, National Yang Ming University, Taipei, Taiwan

Download PDF


Abstract

Treatment-resistant depression is a difficult problem in clinical practice. Evidence for the efficacy of newer antidepressants, such as duloxetine and bupropion, is not yet well established. We present a case of treatment-resistant depression with full recovery where a combination of mirtazapine and bupropion was used after a failed response to combined mirtazapine and duloxetine treatment.


Keywords

Bupropion; Duloxetine; Mirtazapine; Treatment-resistant depression


 

On the Cover

Search all Issue